Literature DB >> 3881375

A multivariate analysis of prognostic factors in early stage Hodgkin's disease.

M Tubiana, M Henry-Amar, B van der Werf-Messing, J Henry, J Abbatucci, M Burgers, M Hayat, R Somers, A Laugier, P Carde.   

Abstract

A multivariate analysis of the prognostic factors was carried out with a Cox model on 1,139 patients with clinical Stage I + II Hodgkin's disease included in three controlled clinical trials. The following indicators had been prospectively registered: age, sex, systemic symptoms, erythrocyte sedimentation rate (ESR), number and sites of involved lymph node areas, histologic type, clinical stage, pattern of presentation, results of staging laparotomy when performed, as well as the date and type of treatment. A linear logistic analysis showed that most of the indicators are interrelated. This emphasizes the necessity of a multivariate analysis in order to assess the independent influence of each of them. The two main prognostic indicators for relapse-free survival are systemic symptoms and/or ESR and number of involved areas. The only significant factor for survival after relapse is age. Sex has a small but significant influence on relapse-free survival. The relative influence of each indicator varies with the type of treatment and these variations may help in understanding the biologic significance of the indicators.

Entities:  

Mesh:

Year:  1985        PMID: 3881375     DOI: 10.1016/0360-3016(85)90358-x

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

Review 1.  The role of radiation therapy in patients with Hodgkin's lymphoma.

Authors:  Berthe M P Aleman; Daniel Re; Volker Diehl
Journal:  Curr Hematol Malig Rep       Date:  2007-07       Impact factor: 3.952

Review 2.  Hodgkin's disease--I: Identification and classification.

Authors:  P Carde
Journal:  BMJ       Date:  1992-07-11

Review 3.  Clinical aspects of Hodgkin's disease.

Authors:  G M Mead; J M Whitehouse
Journal:  BMJ       Date:  1988-12-17

4.  Late cardiopulmonary toxicity after treatment for Hodgkin's disease.

Authors:  C Allavena; T Conroy; P Aletti; P Bey; P Lederlin
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

5.  Chemotherapy alone or combined chemotherapy and involved field radiotherapy in favorable risk early-stage classical Hodgkin lymphoma-a 10 years experience.

Authors:  Sheeraz Ali; Abdul Basit; Ather S Kazmi; Armughan Sidhu; Farhana Badar; Abdul Hameed
Journal:  Pak J Med Sci       Date:  2016 Nov-Dec       Impact factor: 1.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.